Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Saved in:
| Title: | Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. |
|---|---|
| Authors: | Lei, Josh Haipeng (AUTHOR), Lee, Mi‐Hye (AUTHOR), Miao, Kai (AUTHOR), Huang, Zebin (AUTHOR), Yao, Zhicheng (AUTHOR), Zhang, Aiping (AUTHOR), Xu, Jun (AUTHOR), Zhao, Ming (AUTHOR), Huang, Zenan (AUTHOR), Zhang, Xin (AUTHOR), Chen, Si (AUTHOR), Jiaying, NG (AUTHOR), Feng, Yuzhao (AUTHOR), Xing, Fuqiang (AUTHOR), Chen, Ping (AUTHOR), Sun, Heng (AUTHOR), Chen, Qiang (AUTHOR), Xiang, Tingxiu (AUTHOR), Chen, Lin (AUTHOR), Xu, Xiaoling (AUTHOR) |
| Source: | Advanced Science. 12/27/2023, Vol. 10 Issue 36, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21983844 |
|---|---|
| DOI: | 10.1002/advs.202307935 |
